Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine or Meningococcal C Conjugate Vaccine
Clinical trial NCT01345721 · COMPLETED
Trial details
- NCT number
- NCT01345721
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-09-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.